Xcel Energy Resolves Regulatory Issues
The company reached what we consider a fair settlement in Texas and continues toward a constructive conclusion of its rate case in New Mexico.
We are reaffirming our $40 fair value estimate and narrow moat rating for Xcel Energy (XEL) after the company reached what we consider a fair settlement in Texas and continues toward a constructive conclusion of its rate case in New Mexico. These developments support our 6% annual earnings and dividend growth forecast at least through 2021.
The Southwest is becoming a key growth area for Xcel after recent approval of new renewable energy projects and likely constructive outcomes in the pending base rate cases. We expect these regulatory outcomes will support Xcel's plan for $3.3 billion of investment in the region in 2018-21. This would be 21% of Xcel's consolidated $15.9 billion investment plan in a region that contributed only 12% of Xcel's 2017 operating earnings.
The Texas settlement comes with a 9.5% allowed return on equity, which is below industry average, but a higher-than-average 57% equity share, which offsets the lower ROE. The net earnings impact is in line with our estimate due to earnings-neutral offsets such as lower tax rates and accelerated depreciation. We expect Xcel can achieve a similar outcome in New Mexico based on regulatory filings to date.
Colorado, Xcel's second-largest service territory, is a key place for investors to watch next. We expect a ruling this fall on Xcel's $1 billion Colorado Energy Plan, with investments in renewable energy and natural gas power generation. A constructive outcome in Xcel's CEP filing will in part determine the company's growth beyond 2020. We assume a constructive outcome based on state regulators' past support for similar initiatives to reduce reliance on coal.
We also expect constructive outcomes in Xcel's Colorado gas and electric base rate cases. However, a less constructive outcome could lead Xcel to pull back on some of its planned $4.8 billion of investment in the state apart from the CEP. A cut in investment could reduce our fair value estimate by $2 per share.
Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.
Travis Miller does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.